Pharmaselect Handel

Pharmaselect is an Austrian pharmaceutical company headquartered in Vienna, specializing in the development, marketing, and distribution of prescription and over-the-counter (OTC) healthcare products. The company maintains a strong focus on therapeutic areas such as ophthalmology, internal medicine, intensive care, and neurology, serving markets across Europe and the CEE region. Its portfolio includes notable proprietary brands like Colibiogen for gastrointestinal health and a comprehensive range of ophthalmic treatments for conditions such as dry eye and glaucoma. In early 2023, Pharmaselect was acquired by the Lohmann & Rauscher Group, a leading international supplier of medical devices. This acquisition integrates Pharmaselect's pharmaceutical expertise into a broader healthcare solutions framework, leveraging extensive distribution networks to enhance market reach.